These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12933676

  • 21. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

  • 22. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [Abstract] [Full Text] [Related]

  • 23. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
    Shpakov AO, Shpakova EA, Tarasenko II, Derkach KV.
    Tsitologiia; 2014 Aug; 56(7):526-35. PubMed ID: 25696997
    [Abstract] [Full Text] [Related]

  • 24. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoli P, Vitti P.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [Abstract] [Full Text] [Related]

  • 25. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S, Kohn LD, Akamizu T, Mori T.
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [Abstract] [Full Text] [Related]

  • 26. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
    Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, Beck-Peccoz P, Dunlap D, Persani L.
    Hum Mol Genet; 2005 Oct 15; 14(20):2991-3002. PubMed ID: 16135555
    [Abstract] [Full Text] [Related]

  • 27. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
    Holzapfel HP, Bergner B, Wonerow P, Paschke R.
    Eur J Endocrinol; 2002 Jul 15; 147(1):109-16. PubMed ID: 12088927
    [Abstract] [Full Text] [Related]

  • 28. The interaction of signal transduction pathways in FRTL5 thyroid follicular cells: studies with stable expression of beta 2-adrenergic receptors.
    Tsuzaki S, Cone RD, Frazier AL, Moses AC.
    Endocrinology; 1991 Mar 15; 128(3):1359-68. PubMed ID: 1847855
    [Abstract] [Full Text] [Related]

  • 29. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.
    Biebermann H, Winkler F, Handke D, Teichmann A, Gerling B, Cameron F, Eichhorst J, Grüters A, Wiesner B, Kühnen P, Krude H, Kleinau G.
    J Clin Endocrinol Metab; 2012 Feb 15; 97(2):E228-32. PubMed ID: 22112806
    [Abstract] [Full Text] [Related]

  • 30. TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling.
    Bäck CM, Stohr S, Schäfer EA, Biebermann H, Boekhoff I, Breit A, Gudermann T, Büch TR.
    J Mol Endocrinol; 2013 Feb 15; 51(1):79-90. PubMed ID: 23613280
    [Abstract] [Full Text] [Related]

  • 31. Functional significance of the thyrotropin receptor germline polymorphism D727E.
    Sykiotis GP, Neumann S, Georgopoulos NA, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Paschke R, Vagenakis AG, Papavassiliou AG.
    Biochem Biophys Res Commun; 2003 Feb 21; 301(4):1051-6. PubMed ID: 12589819
    [Abstract] [Full Text] [Related]

  • 32. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
    Lueblinghoff J, Eszlinger M, Jaeschke H, Mueller S, Bircan R, Gozu H, Sancak S, Akalin S, Paschke R.
    Thyroid; 2011 Mar 21; 21(3):221-9. PubMed ID: 21190443
    [Abstract] [Full Text] [Related]

  • 33. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S, Ban T, Kohn LD.
    Mol Endocrinol; 1993 Jan 21; 7(1):114-30. PubMed ID: 8095322
    [Abstract] [Full Text] [Related]

  • 34. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
    Lado-Abeal J, Quisenberry LR, Castro-Piedras I.
    Methods Enzymol; 2010 Jan 21; 484():375-95. PubMed ID: 21036242
    [Abstract] [Full Text] [Related]

  • 35. TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes in vitro.
    Boutin A, Krieger CC, Marcus-Samuels B, Klubo-Gwiezdzinska J, Neumann S, Gershengorn MC.
    Front Endocrinol (Lausanne); 2020 Jan 21; 11():276. PubMed ID: 32425890
    [Abstract] [Full Text] [Related]

  • 36. Cloning of the cat TSH receptor and evidence against an autoimmune etiology of feline hyperthyroidism.
    Nguyen LQ, Arseven OK, Gerber H, Stein BS, Jameson JL, Kopp P.
    Endocrinology; 2002 Feb 21; 143(2):395-402. PubMed ID: 11796491
    [Abstract] [Full Text] [Related]

  • 37. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
    Neumann S, Claus M, Paschke R.
    Eur J Endocrinol; 2005 Apr 21; 152(4):625-34. PubMed ID: 15817920
    [Abstract] [Full Text] [Related]

  • 38. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
    Schubert RL, Narayan P, Puett D.
    Endocrinology; 2003 Jan 21; 144(1):129-37. PubMed ID: 12488338
    [Abstract] [Full Text] [Related]

  • 39. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.
    Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J.
    J Clin Endocrinol Metab; 1996 Feb 21; 81(2):547-54. PubMed ID: 8636266
    [Abstract] [Full Text] [Related]

  • 40. Thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) prevents internalization of TSH receptor.
    Picchietti S, Belardinelli M, Taddei AR, Fausto AM, Pellegrino M, Maggio R, Rossi M, Giorgi F.
    Cell Tissue Res; 2009 Apr 21; 336(1):31-40. PubMed ID: 19214582
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.